Nocardia infection in solid organ transplant recipients: a multicenter European case-control study.

Coussement, Julien; Lebeaux, David; van Delden, Christian; Guillot, Hélène; Freund, Romain; Marbus, Sierk; Melica, Giovanna; Van Wijngaerden, Eric; Douvry, Benoit; Van Laecke, Steven; Vuotto, Fanny; Tricot, Leïla; Fernández-Ruiz, Mario; Dantal, Jacques; Hirzel, Cédric; Jais, Jean-Philippe; Rodriguez-Nava, Veronica; Lortholary, Olivier; Jacobs, Frédérique (2016). Nocardia infection in solid organ transplant recipients: a multicenter European case-control study. Clinical infectious diseases, 63(3), pp. 338-345. Oxford University Press 10.1093/cid/ciw241

Preview	Text cid.ciw241.full.pdf - Accepted Version Available under License Publisher holds Copyright. Download (1MB) | Preview
Preview	Text cid.ciw241.full.pdf - Published Version Available under License Publisher holds Copyright. Download (304kB) | Preview

BACKGROUND

Nocardiosis is a rare, life-threatening opportunistic infection, affecting 0.04% to 3.5% of patients after solid organ transplantation (SOT). The aim of this study was to identify risk factors for Nocardia infection after SOT and to describe the presentation of nocardiosis in these patients.

METHODS

We performed a retrospective case-control study of adult patients diagnosed with nocardiosis after SOT between 2000 and 2014 in 36 European (France, Belgium, Switzerland, Netherlands, Spain) centers. Two control subjects per case were matched by institution, transplant date and transplanted organ. A multivariable analysis was performed using conditional logistic regression to identify risk factors for nocardiosis.

RESULTS

One hundred and seventeen cases of nocardiosis and 234 control patients were included. Nocardiosis occurred at a median of 17.5 [range 2-244] months after transplantation. In multivariable analysis, high calcineurin inhibitor trough levels in the month before diagnosis (OR=6.11 [2.58-14.51]), use of tacrolimus (OR=2.65 [1.17-6.00]) and corticosteroid dose (OR=1.12 [1.03-1.22]) at the time of diagnosis, patient age (OR=1.04 [1.02-1.07]) and length of stay in intensive care unit after SOT (OR=1.04 [1.00-1.09]) were independently associated with development of nocardiosis; low-dose cotrimoxazole prophylaxis was not found to prevent nocardiosis. Nocardia farcinica was more frequently associated with brain, skin and subcutaneous tissue infections than were other Nocardia species. Among the 30 cases with central nervous system nocardiosis, 13 (43.3%) had no neurological symptoms.

CONCLUSIONS

We identified five risk factors for nocardiosis after SOT. Low-dose cotrimoxazole was not found to prevent Nocardia infection. These findings may help improve management of transplant recipients.

Interest & Impact

Downloads

947 since deposited on 12 Jul 2016
186 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item